GENTA INCORPORATED /DE/
10-Q, EX-27, 2000-11-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: GENTA INCORPORATED /DE/, 10-Q, 2000-11-14
Next: DECRANE AIRCRAFT HOLDINGS INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED STATEMENTS OF OPERATIONS CONTAINED
IN THE COMPANY'S QUARTERLY REPORT ON FORM 10-Q FOR PERIOD ENDED SEPTEMBER 30,
2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>                     <C>
<PERIOD-TYPE>                   9-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999             DEC-31-2000
<PERIOD-START>                             JAN-01-1999             JAN-01-2000
<PERIOD-END>                               SEP-30-1999             SEP-30-2000
<CASH>                                       1,489,173              20,573,620
<SECURITIES>                                         0               5,150,736
<RECEIVABLES>                                1,372,739               1,325,072
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                             3,368,466              27,128,335
<PP&E>                                          32,910                 185,495
<DEPRECIATION>                                       0                       0
<TOTAL-ASSETS>                               4,062,283              30,559,814
<CURRENT-LIABILITIES>                        1,482,118               1,864,171
<BONDS>                                              0                       0
                                0                       0
                                        400                     269
<COMMON>                                        20,957                  46,532
<OTHER-SE>                                   2,558,808              28,648,842
<TOTAL-LIABILITY-AND-EQUITY>                 4,062,283              30,559,814
<SALES>                                              0                  16,667
<TOTAL-REVENUES>                                     0                       0
<CGS>                                                0                       0
<TOTAL-COSTS>                                6,161,258              14,953,535
<OTHER-EXPENSES>                               149,029                  18,917
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                             138,029                 435,316
<INCOME-PRETAX>                                      0                       0
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                        (3,888,240)            (13,980,690)
<DISCONTINUED>                               (189,407)                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                               (7,691,145)            (17,423,251)
<EPS-BASIC>                                     (0.48)                  (0.50)
<EPS-DILUTED>                                   (0.48)                  (0.50)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission